» Articles » PMID: 31932459

The Prevalence and Determinants of Cognitive Deficits and Traditional Diabetic Complications in the Severely Obese

Overview
Journal Diabetes Care
Specialty Endocrinology
Date 2020 Jan 15
PMID 31932459
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To determine the prevalence of cognitive deficits and traditional diabetic complications and the association between metabolic factors and these outcomes.

Research Design And Methods: We performed a cross-sectional study in severely obese individuals before bariatric surgery. Lean control subjects were recruited from a research website. Cognitive deficits were defined by the National Institutes of Health (NIH) Toolbox (<5th percentile for lean control subjects). Cardiovascular autonomic neuropathy (CAN) was defined by an expiration-to-inspiration (E-to-I) ratio of <5th percentile for lean control subjects. Retinopathy was based on retinal photographs and nephropathy on the estimated glomerular filtration rate (<60 mg/dL) and/or the albumin-to-creatinine ratio (ACR) (≥30 mg/g). NIH Toolbox, E-to-I ratio, mean deviation on frequency doubling technology testing, and ACR were used as sensitive measures of these outcomes. We used multivariable linear regression to explore associations between metabolic factors and these outcomes.

Results: We recruited 138 severely obese individuals and 46 lean control subjects. The prevalence of cognitive deficits, CAN, retinopathy, and nephropathy were 6.5%, 4.4%, 0%, and 6.5% in lean control subjects; 22.2%, 18.2%, 0%, and 6.1% in obese participants with normoglycemia; 17.7%, 21.4%, 1.9%, and 17.9% in obese participants with prediabetes; and 25.6%, 31.9%, 6.1%, and 16.3% in obese participants with diabetes. Waist circumference was significantly associated with cognitive function (-1.48; 95% CI -2.38, -0.57) and E-to-I ratio (-0.007; 95% CI -0.012, -0.002). Prediabetes was significantly associated with retinal function (-1.78; 95% CI -3.56, -0.002).

Conclusions: Obesity alone is likely sufficient to cause cognitive deficits but not retinopathy or nephropathy. Central obesity is the key metabolic risk factor.

Citing Articles

Cognitive impairment and associated factors among patients with diabetes mellitus in Africa: a systematic review and meta-analysis.

Tassew W, Ferede Y, Zeleke A Front Endocrinol (Lausanne). 2024; 15():1386600.

PMID: 39086905 PMC: 11288936. DOI: 10.3389/fendo.2024.1386600.


Prevalence and Risk Factors of Distal Symmetric Polyneuropathy Among Predominantly Non-Hispanic Black, Low-Income Patients.

Elafros M, Brown A, Marcus H, Dawood T, Bachuwa G, Banerjee M Neurology. 2024; 102(11):e209390.

PMID: 38718313 PMC: 11175633. DOI: 10.1212/WNL.0000000000209390.


Prevalence of Retinopathy in Prediabetic Populations: A Systematic Review and Meta-Analysis.

Sune M, Sune M, Sune P, Dhok A Cureus. 2024; 15(11):e49602.

PMID: 38161917 PMC: 10755086. DOI: 10.7759/cureus.49602.


The Effect of Surgical Weight Loss on Cognition in Individuals with Class II/III Obesity.

Reynolds E, Votruba K, Watanabe M, Banerjee M, Elafros M, Chant E J Nutr Health Aging. 2023; 27(12):1153-1161.

PMID: 38151865 PMC: 11100299. DOI: 10.1007/s12603-023-2047-1.


Association between brain health outcomes and metabolic risk factors in persons with diabetes.

Reynolds E, Votruba K, Jack C, Beare R, Reid R, Preboske G Ann Clin Transl Neurol. 2023; 10(10):1891-1898.

PMID: 37518982 PMC: 10578900. DOI: 10.1002/acn3.51859.


References
1.
Lauria G, Hsieh S, Johansson O, Kennedy W, Leger J, Mellgren S . European Federation of Neurological Societies/Peripheral Nerve Society Guideline on the use of skin biopsy in the diagnosis of small fiber neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the.... Eur J Neurol. 2010; 17(7):903-12, e44-9. DOI: 10.1111/j.1468-1331.2010.03023.x. View

2.
OBrien P, Hinder L, Callaghan B, Feldman E . Neurological consequences of obesity. Lancet Neurol. 2017; 16(6):465-477. PMC: 5657398. DOI: 10.1016/S1474-4422(17)30084-4. View

3.
Callaghan B, Xia R, Banerjee M, de Rekeneire N, Harris T, Newman A . Metabolic Syndrome Components Are Associated With Symptomatic Polyneuropathy Independent of Glycemic Status. Diabetes Care. 2016; 39(5):801-7. PMC: 4839175. DOI: 10.2337/dc16-0081. View

4.
Porta M, Sjoelie A, Chaturvedi N, Stevens L, Rottiers R, Veglio M . Risk factors for progression to proliferative diabetic retinopathy in the EURODIAB Prospective Complications Study. Diabetologia. 2002; 44(12):2203-9. DOI: 10.1007/s001250100030. View

5.
Ng T, Feng L, Nyunt M, Feng L, Gao Q, Lim M . Metabolic Syndrome and the Risk of Mild Cognitive Impairment and Progression to Dementia: Follow-up of the Singapore Longitudinal Ageing Study Cohort. JAMA Neurol. 2016; 73(4):456-63. DOI: 10.1001/jamaneurol.2015.4899. View